bluebird bio Inc (NAS:BLUE)
$ 0.9624 0.06 (6.64%) Market Cap: 185.50 Mil Enterprise Value: 303.88 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 25/100

bluebird bio Inc EHA Data Review - Call Transcript

Jun 12, 2020 / 12:00PM GMT
Release Date Price: $41.38 (+1.28%)
Operator

Ladies and gentlemen, thank you for standing by. Over to the bluebird EHA ASCO webcast. (Operator Instructions)

I would now like to hand the conference to your speaker today, Ingrid Goldberg. Please go ahead, ma'am.

Ingrid Goldberg
bluebird bio, Inc. - VP of IR

Thank you and good morning, everyone. And thank you for joining this morning's call to discuss clinical data presented at the recent ASCO and EHA meetings. The format for today's call will be brief opening remarks from Nick, and then Joanne will introduce the ide-cel data from ASCO, which will be presented by Anna Truppel-Hartmann, our VP of Late-Stage Oncology Clinical Development. Dave will then walk through the clinical data on beta-thalassemia and sickle cell disease from EHA. And for the Q&A portion, Chip and Philip will also be on the call.

Before we begin, I would like to remind everyone that we make forward-looking statements about future plans and prospects on this call. Actual results may differ materially as a result of various important factors, including those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot